Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment …
G Martinotti, B Dell'Osso, G Di Lorenzo… - Bipolar …, 2023 - Wiley Online Library
Background Bipolar depression accounts for most of the disease duration in type I and type
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment …
G Martinotti, B Dell'Osso, G Di Lorenzo… - BIPOLAR …, 2023 - ricerca.uniba.it
BackgroundBipolar depression accounts for most of the disease duration in type I and type II
bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do …
bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do …
[PDF][PDF] Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar …
G Martinotti, B Dell'Osso, G Di Lorenzo, G Maina… - 2023 - academia.edu
Background: Bipolar depression accounts for most of the disease duration in type I and type
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment …
G Martinotti, B Dell'Osso, G Di Lorenzo, G Maina… - Bipolar …, 2023 - uhra.herts.ac.uk
Background: Bipolar depression accounts for most of the disease duration in type I and type
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
Treating Bipolar Depression with Esketamine: Safety and Effectiveness data from a naturalistic multicentric study on Esketamine in Bipolar versus Unipolar Treatment …
G Martinotti, B Dell'Osso, G Di Lorenzo, G Maina… - Bipolar …, 2023 - europepmc.org
Bipolar depression accounts for most of the disease duration in type I and type II bipolar
disorder (BD), with few treatment options, often poorly tolerated. Many individuals do not …
disorder (BD), with few treatment options, often poorly tolerated. Many individuals do not …
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment …
G Martinotti, B Dell'Osso, G Di Lorenzo… - Bipolar …, 2023 - search.ebscohost.com
Background: Bipolar depression accounts for most of the disease duration in type I and type
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
[PDF][PDF] Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar …
G Martinotti, B Dell'Osso, G Di Lorenzo, G Maina… - 2023 - giovannimartinotti.com
Background: Bipolar depression accounts for most of the disease duration in type I and type
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment …
G Martinotti, B Dell'Osso, G DI LORENZO… - BIPOLAR …, 2023 - art.torvergata.it
BackgroundBipolar depression accounts for most of the disease duration in type I and type II
bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do …
bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do …
[PDF][PDF] Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar …
G Martinotti, B Dell'Osso, G Di Lorenzo, G Maina… - 2023 - researchgate.net
Background: Bipolar depression accounts for most of the disease duration in type I and type
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment …
G Martinotti, B Dell'Osso, G Di Lorenzo… - Bipolar …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Bipolar depression accounts for most of the disease duration in type I and type
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …
II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals …